Founded in 2007 by two postdoctoral researchers from the University of Uppsala determined to discover new capabilities for ALD beyond industrial electronics, Nanexa now has its first Phase I clinical study underway and is developing the world’s first GMP pharma manufacturing plant with industrial Atomic Layer Deposition capabilities.
- Anders Johansson, Nanexa’s co-founder and Head of Intellectual Property, on Nanexa’s origins and development.
